MedTrace Logo

Research Evaluating the Value of Augmenting Medication With Psychotherapy

NCT00057551 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 491

Last updated 2017-12-06

Study results available
· View outcomes & findings →

Summary

This 24-week study, with a 12-month follow up period, will compare the effectiveness of antidepressant medication alone to the combination of psychotherapy and antidepressant medication in patients with chronic depression.

Conditions

Interventions

BEHAVIORAL

Brief Supportive Psychotherapy

brief supportive psychotherapy

BEHAVIORAL

CBASP

psychotherapy developed for chronic depression

DRUG

Medication Only

antidepressant medication

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • James H Kocsis · weill cornell mc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2007-03-31
Completion
2007-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00057551 on ClinicalTrials.gov